427 related articles for article (PubMed ID: 17903153)
1. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases.
Farhi D; Dupin N; Palangié A; Carlotti A; Avril MF
Dermatol Surg; 2007 Oct; 33(10):1207-14. PubMed ID: 17903153
[TBL] [Abstract][Full Text] [Related]
2. Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners.
Hansen C; Wilkinson D; Hansen M; Soyer HP
Arch Dermatol; 2009 Nov; 145(11):1253-60. PubMed ID: 19917954
[TBL] [Abstract][Full Text] [Related]
3. Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty.
Talbot S; Hitchcock B
N Z Med J; 2004 Apr; 117(1192):U848. PubMed ID: 15107870
[TBL] [Abstract][Full Text] [Related]
4. The incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit.
Hussain M; Earley MJ
Ir Med J; 2003 Jan; 96(1):18-20. PubMed ID: 12617437
[TBL] [Abstract][Full Text] [Related]
5. Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management.
Codazzi D; Van Der Velden J; Carminati M; Bruschi S; Bocchiotti MA; Di Serio C; Barberis M; Robotti E
J Plast Surg Hand Surg; 2014 Feb; 48(1):38-43. PubMed ID: 23731130
[TBL] [Abstract][Full Text] [Related]
6. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
[TBL] [Abstract][Full Text] [Related]
7. Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.
Hamada S; Kersey T; Thaller VT
Br J Ophthalmol; 2005 Aug; 89(8):992-4. PubMed ID: 16024851
[TBL] [Abstract][Full Text] [Related]
8. An assessment of incomplete facial Basal cell carcinoma excision.
Shah SA; Obaidullah ; Fahimullah
J Coll Physicians Surg Pak; 2005 Mar; 15(3):149-51. PubMed ID: 15808092
[TBL] [Abstract][Full Text] [Related]
9. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
[TBL] [Abstract][Full Text] [Related]
10. [Basal cell carcinoma of the nose].
Bonvallot T; Raulo Y; Zeller J; Faivre JM; Horn G; Baruch J
Ann Dermatol Venereol; 1993; 120(3):209-14. PubMed ID: 8239358
[TBL] [Abstract][Full Text] [Related]
11. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of basal cell carcinomas: an audit of current practice.
Mc Loone NM; Tolland J; Walsh M; Dolan OM
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):698-701. PubMed ID: 16836498
[TBL] [Abstract][Full Text] [Related]
13. Recurrent morphean basal cell carcinoma of the skin. A clinico-histopathological study of 97 cases.
Anthouli-Anagnostopoulou F; Hatziolou E
Adv Clin Path; 2002 Jan; 6(1):17-24. PubMed ID: 17582944
[TBL] [Abstract][Full Text] [Related]
14. [Low 5-year recurrence rate after surgical excision of 126 basal cell carcinomas with frozen section analysis upon indication].
van der Meer GT; Willemse F; Marck KW
Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1409-13. PubMed ID: 11494691
[TBL] [Abstract][Full Text] [Related]
15. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
16. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
17. Incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit.
Kumar P; Orton CI; McWilliam LJ; Watson S
Br J Plast Surg; 2000 Oct; 53(7):563-6. PubMed ID: 11000071
[TBL] [Abstract][Full Text] [Related]
18. Histologic safety margin in basal cell carcinoma of the eyelid: correlation with recurrence rate.
Auw-Haedrich C; Frick S; Boehringer D; Mittelviefhaus H
Ophthalmology; 2009 Apr; 116(4):802-6. PubMed ID: 19232734
[TBL] [Abstract][Full Text] [Related]
19. Basal cell carcinomas: do they need to be followed up?
Park AJ; Strick M; Watson JD
J R Coll Surg Edinb; 1994 Apr; 39(2):109-11. PubMed ID: 7520063
[TBL] [Abstract][Full Text] [Related]
20. The specialty of the treating physician affects the likelihood of tumor-free resection margins for basal cell carcinoma: results from a multi-institutional retrospective study.
Fleischer AB; Feldman SR; Barlow JO; Zheng B; Hahn HB; Chuang TY; Draft KS; Golitz LE; Wu E; Katz AS; Maize JC; Knapp T; Leshin B
J Am Acad Dermatol; 2001 Feb; 44(2):224-30. PubMed ID: 11174379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]